Daily News

House E&C health subcommittee rejects Price request to reopen user fees . . .

FDA User Fee Package Advances To Full E&C Committee By Voice Vote

May 18, 2017
A House subcommittee easily passed FDA user fee legislation Thursday (May 18) with riders allowing over-the-counter hearings aids, requiring risk-based device inspections, offering new exclusivity for a new class of competitive generic drugs and restricting drug imports, and in the process brushed off the Trump administration's call for a doubling of the user fee levels FDA negotiated with industry. The vote moves the Food and Drug Administration Reauthorization Act of 2017 (FDARA) to the full Energy & Commerce Committee. E&C...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to the Senate and its coming consideration of the American Health Care Act.